• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

Poor MS symptom control associated with unemployment

May 12, 2010  

New FDA warning for Tysabri

April 28, 2010  

Chronic cerebrospinal venous insufficiency (CCSVI)

February 16, 2010  

Assessing the nocebo effect in MS trials

January 5, 2010  

Pulsed methylprednisolone: MECOMBIN trial results

January 5, 2010  

Teriflunomide in combination with beta-IFN: preliminary results

January 5, 2010  

Cognitive impairment in adolescent MS: follow-up results

December 15, 2009  

Alemtuzumab in MS: 4-year follow-up

December 15, 2009  

Vitamin D in MS: update on new studies

December 15, 2009  

EBV: an association with MS?

November 3, 2009  
Previous
40
41
42
43
44
Next

Browse by Topic

  • MS (445)
  • MSToronto2026 (1)
  • CLINICAL CASES (22)
  • EAN 2026 (2)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • CLINICAL CASES IN NEUROLOGY – A YOUNG WOMAN WITH MILD EARLY MS posted on September 17, 2026
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Ofatumumab 2026 – update on real-world effectiveness posted on September 22, 2026
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions